Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.65432 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.66039 | 61 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.64917 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.53797 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.58544 | 61 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.79396 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.77714 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.63765 | 61 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.66057 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.66905 | 62 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.6612 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.65801 | 62 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.65747 | 61 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.66546 | 61 |